Stephanie Lewis

Title: Stephanie Lewis: Innovator in Chemical Synthesis

Introduction

Stephanie Lewis is a notable inventor based in Coventry, NY (US). She has made significant contributions to the field of chemical synthesis, particularly in the development of processes that aid in the creation of important pharmaceutical compounds. Her work is characterized by a commitment to innovation and a focus on practical applications in medicine.

Latest Patents

Stephanie holds a patent for a process for the synthesis of substituted piperazinones via Mitsunobu. This invention is directed towards synthesizing substituted piperazinones, which serve as useful intermediates for creating farnesyl-protein transferase inhibitors. This process showcases her expertise in organic chemistry and her ability to contribute to advancements in drug development.

Career Highlights

Stephanie is currently employed at Merck & Company, Inc., a leading global healthcare company. Her role at Merck allows her to work on cutting-edge research and development projects that aim to improve health outcomes through innovative pharmaceutical solutions.

Collaborations

Throughout her career, Stephanie has collaborated with esteemed colleagues, including David Askin and Steven A Weissman. These partnerships have enabled her to enhance her research and contribute to a collaborative environment that fosters innovation.

Conclusion

Stephanie Lewis is a remarkable inventor whose work in chemical synthesis has the potential to impact the pharmaceutical industry significantly. Her dedication to innovation and collaboration exemplifies the spirit of modern scientific research.